AstraZeneca — fllwup^ https://fllwup.co/topic/astrazeneca/ Track AstraZeneca news in real time — Anglo-Swedish pharmaceutical company with major oncology, cardiovascular, and rare disease franchises.. fllwup^ collects the latest AstraZeneca headlines from every major source into one live feed — free, no account, no algorithm. Sat, 22 Aug 2026 19:29:19 GMT BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZenecahttps://news.google.com/rss/articles/CBMipgFBVV95cUxQaG1fcFNwME5RSDE1a2JsX3BXUHl3VjVic281Q2Z2YkpkaGdtVVF2ay1oREJCc0FhcVVLT0dOVlZxdWZIajF2UkpYd3dKbUNoQWZHQTN1T0V3aEI3bnljc1ZNbFY4alFqdXJKZFZ3Z2xPdVVCVzdyeDI0b2dla2NoZDZJY3dTazV5ZnAyM1k3LWlBVlpWWS1KV0g2UTdaYUpBWXpmVU5R?oc=5Fierce Biotech AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Reviewhttps://news.google.com/rss/articles/CBMiqwFBVV95cUxQTFRONjBRZlJ6WHJHXzkwbTBUNWZqRUlubzFlSU4wdUVValVxMm5oaTFHZGhQNnEwaVZkeUZuZVUtTzN1SDlpdUt3Y0xuV2lwblpWQ2Z1TWJCSU9GaXZEcHdzTzJuYXV3UVZ0MEM2YVpnUnkyZ0Izb1hQNjRIOExMLUt2MmJELUlndjdJSG9ZS2hDRU5QTWh6U0RtZnlGQmNHVmJCVXlMblRXMG8?oc=5WSJ AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failurehttps://news.google.com/rss/articles/CBMitwFBVV95cUxPQ3FhazNOMDNYR2Nhd3dWMG1jUU5ibkJ6dXRhU3B5VzlXQkRoQXg0RXNhNDVWRFNHUVhiNWFXU1JNQldDMlBVbmRmUjJ5Ti11blRWdXF3VmJDakh1NGpHZEEtWDk4SFJWcmE4NkFWaTFab2dNZzRZbUpVa3dpM0tkUFRuRFpHTnJhZlZpT0ktVWxiVWc2Skh5c25QZmFad0pZMC1jUG9vSDBDOG9mUlVaaGxiSHZrbGs?oc=5Fierce Pharma AstraZeneca oncology veteran Alan Barge named CEO of 4C Biomedhttps://news.google.com/rss/articles/CBMiqwFBVV95cUxQYXBvcGNsNmpHOE1XY0tFRW11ZXZIaFBqWGZZbGY5MFJaQVFKSmFwRUNfaVlSVGVfVUYzdG9ibGZMdnFnY2VkS0hBdk1MNXlhejRFd0tjWWRYcjBwcm4tWXZER3VUdlpncGJDeGI2OWpyUGNURVFWTXBiQS0ydG1LbjYyemhRc1NIZm5NRWNQaU5tZmtPN21UX0VYaGpsajZLckVXdG5GSjJUSUU?oc=5The Pharma Letter AstraZeneca touts separate late-stage lung cancer wins with Tagrisso, Enhertuhttps://news.google.com/rss/articles/CBMiogFBVV95cUxQekxqdEpWNmx2bWVhU1Q0WVN4Q0l6RFNPNDIyb0hZQXdENWZsa1phOE5jcGNNV2lWQWpWNUpZdzh4MlNOMWdXRUVCZ21mTk9tNElqLS1SY0VwTEY1WUpFdzA5cklEcmF0WWNrWjNPSWlzSFdFVnl2dnlWS3prRnJuekN2dXIyNXZDdzQ4c1psaVR5S19neWI0ZGlIeUxXQnBGRmc?oc=5Endpoints News AstraZeneca Vs. Bristol-Myers Squibb: Who’s The Better Bargain For Investors (NYSE:BMY)https://news.google.com/rss/articles/CBMitAFBVV95cUxPZjlOMEhMTE10TGo0cFhDbTU2X2pfYXM2bjZHMHo3NUk2dmEtbFpobkNSX0NGdEQ5a1JMNjBmMmJmTC1heWNKNnBZSkpsMklCeHNxUjJDQW0zTWpLUzNaTWRKR2pjVS1Ga3Yza0hiYlFHaFJuVnk5NEI1bmJwb2xOeEg4RlhobGNMRkhVMTZ0VURrcjQ4SFpjVWM1akJMdHN5YS1XUHhUYzV5dHVtaV9VU0ZFaGM?oc=5Seeking Alpha Pharmalittle: We're reading about an AstraZeneca setback, falling U.S. drug prices, and morehttps://news.google.com/rss/articles/CBMinwFBVV95cUxNQlo2OGtmS3NHMW1LSl9oWV9QZTVPb0ZsWTRCSXNTeXJmeDBkM291MGtKTTVacGpGa0dYdjA1RFpwLXhETTJPTGQ3RGIwQ0JfV0ZnVEx6TzBsUU15QXJfeUMtV1piaDFBNFdTNi1HUS02aGlzQjl4MHdhOUhWSFdTZ0h1WHJLdHVQZHpyV3daTEJnbHNVOHV0ckNSaUw3ZTA?oc=5STAT AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blowhttps://news.google.com/rss/articles/CBMiwwFBVV95cUxQajgxU0ZjWFpJVWRYWTRKQlFzV19Oc3V1M1JBTHIyS3REMnJzdjhuZFVfTTVrbEJ2OC1FUjdsXzNnakdEbk15MjVnSWpkaTllQllNYmpBZHp6R0V2aUxFV0JIOHhqNlY0UzMzaXRqa0wyWE5CNjR0WWZRWEFiN2U1WTMyQ043dGlaZkRTUVZwZ2NVRlpBbjJDQkpteTdHa3IwYlBpdmpKRExuNXJyNTVpc0s4YnRuSkZlTUsxQ2NCVE9xTXM?oc=5BioSpace AstraZeneca to discontinue eVOLVE-Lung02 Phase III trialhttps://news.google.com/rss/articles/CBMiqgFBVV95cUxNYmJ1Rnl4V245WnNOMTFCVEJzOWhqV282Qk4wMmNtV1lnYlBObFJ5S1kzdzByVEpIQlhZVTlHa05fQjZDeWFTV0FDeHVnZDA2QlI0YnRsMHd4SWxUMXV3WXJZQk5wNEhhckhWSFJpSlBDd1F1VXNIaGVrZktrbXpZRWlSRkgwTzlXQ2VaQ2RoVG1LbmZVc1pqcHJTRlBybzVRY3B6YmRGNEo2UQ?oc=5TipRanks AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reportshttps://news.google.com/rss/articles/CBMipgFBVV95cUxQemlpUVZvYjZlTkR4cWxEZ0d4M2thWW5nX3p1X2Rhb1NrQ3ZFc3hfb3JSOGY2WHJRZ0VWVlNDSDV4NEhGaFhMaDFPTG9EejV6TTJLYjdDdTA0QUZ3a0hTZFRqUVA4QVZNVEs1cUVIR0t5QXBoNGVQWUREcEx6bG01M3c3NWZKazJtNnpBU2M3ZzRrS3pfb2xtcU1mU0tUbHV5T1ZYUkNB0gGrAUFVX3lxTE1mektIeHVLTTFZZ2ZWLXJfTkFFQm9xaThmSUJsa0M2OHpzMkoyay1FTUxzOWp5RDF1S20tUV9nOFVWMERqODN1YWZPVnFZTXBZWngxS0FudzlrT1U4NUVTa0F5SjJsV3F5bzdFeE9mUDluai1HZUZDaHFWQTRJTG9MSk8zVUNnSWpOdGpOeDY0RzBkLW8tQ3dkVWt3cVJ6aDBjN1dLZnJieFNDNA?oc=5CNBC